Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
AlphaVest Acquisition Unit | ATMVU | Jan 15, 2025 | 11.31 | 0.00 |
Alpine Income Property | PINE | Jan 15, 2025 | 16.79 | +0.24 |
Alps Alerian MLP ETF | AMLP | Jan 15, 2025 | 50.79 | +0.59 |
Alps Equal Sector Weight ETF | EQL | Jan 15, 2025 | 127.23 | +1.27 |
Alps International Sector Divid | IDOG | Jan 15, 2025 | 29.17 | +1.15 |
Alps Sector Dividend Dogs ETF | SDOG | Jan 15, 2025 | 57.14 | +0.76 |
Alset EHome International | AEI | Jan 15, 2025 | 0.88 | +0.01 |
Alt5 Sigma | ALTS | Jan 15, 2025 | 6.09 | -0.65 |
Alta Equipment A Pref | ALTG-A | Jan 15, 2025 | 25.56 | -1.11 |
Alta Equipment Group A | ALTG | Jan 15, 2025 | 7.22 | +5.25 |
Altair Engineering A | ALTR | Jan 15, 2025 | 110.23 | -0.15 |
Altamira Therapeutics | CYTO | Jan 15, 2025 | 0.41 | 0.00 |
AltEnergy Acquisition A | AEAE | Jan 15, 2025 | 11.22 | 0.00 |
AltEnergy Acquisition Unit | AEAEU | Jan 15, 2025 | 11.30 | 0.00 |
Alterity Therapeutics ADR | ATHE | Jan 15, 2025 | 3.31 | +0.09 |
Alternus Clean Energy A | ALCE | Jan 15, 2025 | 0.53 | +1.15 |
Alti Global A | ALTI | Jan 15, 2025 | 4.14 | +1.97 |
Altice USA A | ATUS | Jan 15, 2025 | 2.66 | +5.14 |
Altimmune | ALT | Jan 15, 2025 | 6.58 | +5.62 |
Altisource Portfolio Solutions | ASPS | Jan 15, 2025 | 0.69 | -1.29 |
Alto Ingredients | ALTO | Jan 15, 2025 | 1.65 | +2.48 |
Alto Neuroscience | ANRO | Jan 15, 2025 | 4.30 | -3.15 |
Altria Group | MO | Jan 15, 2025 | 51.04 | -0.62 |
Altus Power A | AMPS | Jan 15, 2025 | 3.84 | -3.27 |
Alumis | ALMS | Jan 15, 2025 | 7.73 | +1.18 |
Alvotech | ALVO | Jan 15, 2025 | 13.20 | -0.83 |
ALX Oncology | ALXO | Jan 15, 2025 | 1.63 | +2.52 |
Alzamend Neuro | ALZN | Jan 15, 2025 | 1.17 | +3.54 |
Amalgamated Financial | AMAL | Jan 15, 2025 | 35.37 | +3.39 |
Amarin ADR | AMRN | Jan 15, 2025 | 0.56 | +9.12 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.